SMART trial: Contemporary Critique of Trial Design & Findings

Update: 2024-05-06

Description

Don't miss this crucial episode of the Structural Heart Podcast, where we dive into the SMART trial data and evaluate it from two perspectives. We're honored to be joined by cardiothoracic surgeon Dr. Dan O'Hair and one of the SMART trial's PIs, Dr. Hemal Gada. This discussion is not just about the Evolut and Sapien valve platforms but also about what this data means for patients. Stay tuned as they share their critical interpretations of the SMART Trial.

Comments

In Channel

Mindset Matters: Stress on Cardiovascular Interventions

2025-05-1926:51

Clinical Insights from the SMART 2y and Low Risk 5y TAVR Trials

2025-04-1827:47

Pioneering Structural Heart Interventions, the journey of Dr. Ashok Seth on TAVR, Innovation & the Future of Cardiology

2025-02-1133:08

Women and aortic stenosis, evidence practice review of the SMART trial results.

2025-01-2927:24

Evolution of TAVR valve design and the implications for valve durability and lifetime management.

2024-12-1727:59

Coronary Access Post-TAVR and Other Hot Topics with Dr. Attizzani

2024-11-2133:08

Navigating Lifetime Management of TAVR with Dr. Michael Reardon

2024-11-0419:49

Modern Perspectives on Cardiothoracic and Structural Heart Innovation

2024-09-1820:01

Lifetime Management : TAVR considerations for Future Interventions

2024-08-0126:32

SMART trial: Contemporary Critique of Trial Design & Findings

2024-05-0623:58

CV Review Low Risk trials - TAVR analysis. Host:Dan O'Hair, MD, featured guest: Hemal Gada, MD

2024-04-1119:53

00:00

SMART trial: Contemporary Critique of Trial Design & Findings

#box-pro-ellipsis-176098764477567{-webkit-line-clamp:2;}SMART trial: Contemporary Critique of Trial Design & Findings

SMART trial: Contemporary Critique of Trial Design & Findings

SH

SMART trial: Contemporary Critique of Trial Design & Findings